Output details
15 - General Engineering
Queen Mary University of London
Osteoinductive ceramics as a synthetic alternative to autologous bone grafting.
This paper reports the development of an entirely new class of calcium phosphate biomaterials that leads to induction and regeneration of bone. Their bone regeneration potential is similar to that of the clinical gold standard autograft and bone growth factor rhBMP2 (annual sales totalling 1 billion US$) and they are superior over all other synthetic biomaterials. The results have aided in a commercial contract between Progentix and NuVasive totalling US$80 million, 9 invited (keynote) lectures and will lead to altered clinical practise (to date more than 10,000 devices have been implanted in the US, EU, Australia, New Zealand and Brazil).